Episode Archive - Page 5 of 6 - ACEP Now

August 2021: Live from the Leadership & Advocacy Conference

August 27, 2021 - Cedric Dark, MD, MPH, FACEP - 0 Comment

In this month’s episode of ACEP Nowcast, Dr. Cedric Dark and Dr. L. Anthony Cirillo talk about the importance of advocacy and ACEP’s goals for this year’s conference in Washington, D.C.

July 2021: Neurological Assessments

August 12, 2021 - Jeremy Samuel Faust, MD, MS, MA, FACEP - 0 Comment

In this month’s episode of ACEP Nowcast, Dr. Jeremy Faust reviews some tips and tricks for evaluating neurological conditions in the emergency department, how to prepare to testify at a malpractice case, and more highlights from ACEP committees and sections, and other highlights from ACEP Now’s July issue.

June 2021: Pulmonary Embolism Management

July 6, 2021 - Jeremy Samuel Faust, MD, MS, MA, FACEP - 0 Comment

In this month’s episode of ACEP Nowcast, Dr. Jeremy Faust discusses outpatient management of pulmonary embolisms, highlights from ACEP committees and sections, and other highlights from ACEP Now’s June issue.

May 2021: Sepsis Task Force

July 2, 2021 - Jeremy Samuel Faust, MD, MS, MA, FACEP - 0 Comment

ACEP Sepsis Task Force Report Delivers Key Insights

In this month’s episode of ACEP Nowcast, Dr. Jeremy Faust discusses ACEP’s sepsis task force, countering COVID-19 vaccine hesitancy, and other highlights from ACEP Now’s May issue.

April 2021: Becoming the COVID Patient

July 1, 2021 - Jeremy Samuel Faust, MD, MS, MA, FACEP - 0 Comment

Dr. Ramon Johnson donating convalescent serum after recovering from COVID-19.

In this month’s episode of ACEP Nowcast, Dr. Jeremy Faust highlights emergency physicians who shared their COVID recovery stories, biomarkers in traumatic brain injury, and other highlights from ACEP Now’s April issue.

March 2021: Patient Access to Medical Records

June 9, 2021 - Jeremy Samuel Faust, MD, MS, MA, FACEP - 0 Comment

In this month’s episode of ACEP Nowcast, Dr. Jeremy Faust discusses a law that gives patients access to clinician notes in their medical records, managing patellar versus knee dislocations, and other highlights from ACEP Now’s March issue.

February 2021: Pulse Oximetry in COVID-19

May 14, 2021 - Jeremy Samuel Faust, MD, MS, MA, FACEP - 0 Comment

In this month’s episode of ACEP Nowcast, Dr. Jeremy Faust discusses the use of home pulse oximetry monitoring for COVID-19, cannabinoid hyperemesis syndrome, and other highlights from ACEP Now’s February issue.

January 2021: COVID-19 Vaccines

February 2, 2021 - Jeremy Samuel Faust, MD, MS, MA, FACEP - 0 Comment

Emergency physician Felipe Grimaldo, MD, FACEP, receives his COVID-19 vaccine.

In this month’s episode of ACEP Nowcast, Dr. Jeremy Faust discusses the new COVID-19 vaccines, out-of-network billing legislation, and other highlights from ACEP Now’s January issue.

December 2020: Year in Review

January 7, 2021 - Jeremy Samuel Faust, MD, MS, MA, FACEP - 0 Comment

In this month’s episode of ACEP Nowcast, Dr. Jeremy Faust discusses top articles from 2020, research highlights from the past year, and other highlights from ACEP Now’s December issue.

November 2020: COVID-19 Vaccines

December 7, 2020 - Jeremy Samuel Faust, MD, MS, MA, FACEP - 0 Comment

shut by Landon Jones, MD, and Richard M. Cantor, MD, FAAP, FACEP The best questions often stem from the inquisitive learner. As educators, we love, and are always humbled by, those moments when we get to say, “I don’t know.” For some of these questions, you may already know the answers. For others, you may never have thought to ask the question. For all, questions, comments, concerns, and critiques are encouraged. Welcome to the Kids Korner. Antibiotics for Strep Question 1: In children with group A strep pharyngitis, what benefit(s) does antibiotic treatment offer? While a potentially reasonable argument may be made about deferring antibiotic treatment of GAS-positive pharyngitis, is antibiotic treatment beneficial? To begin, an earlier RCT by Nelson evaluated 35 children ages 5–11 years with GAS confirmed by culture and randomized patients to penicillin (PCN) treatment or placebo.1 Follow-up visits occurred at 48 hours. Patients treated with PCN had a significantly shorter duration of fever at follow-up, with 28 percent of placebo patients having persistent fever >48 hours but no treated patients having persistent fever (P=0.031). At 48-hour follow-up, children receiving PCN also had significantly shortened times until improved (P=0.008) and until well (P=0.022). A similar shortened duration of fever at 48 hours was seen in another RCT by Pichichero et al.2 A Cochrane meta-analysis by Spinks et al evaluated 27 trials with 12,835 total cases.3 This included both adults and children and included patients with the diagnosis of sore throat, not specifically GAS. Regarding antibiotics versus placebo, the risk ratio of the incidence of developing the secondary complication of otitis media within 14 days following GAS pharyngitis antibiotic treatment was 0.30 (95 percent CI, 0.15–0.58; 11 studies), suggesting that antibiotic therapy decreased the incidence of the complication of otitis media. Similarly, the risk ratio of the incidence of developing “quinsy”—meaning peritonsillar abscess or retropharyngeal abscess—within two months following GAS antibiotic treatment was 0.15 (95 percent CI, 0.05–0.47; eight studies). Lastly, the risk ratio of the incidence of developing acute rheumatic fever (ARF) within two months was 0.27 (95 percent CI, 0.1–0.50; 14 studies). While ARF is traditionally rare in Western countries (

In this month’s episode of ACEP Nowcast, Dr. Jeremy Faust discusses COVID-19 vaccines being developed, treating strep throat in children, when to send COVID-19 patients home, and other highlights from ACEP Now’s November issue.